Drug Pricing Tracker

How much does each drug cost? Global list-price tracker across 50+ countries with reimbursement status, annual cost in USD, and per-country breakdowns. Sourced from CMS, NHS, G-BA, CEPS, and manufacturer disclosures.

List-price comparisons across 50+ countries. Patient out-of-pocket depends on insurance + rebates and is typically 30–60% lower in the US. International public-payer net prices are roughly equivalent to list since rebates are rare in single-payer systems.

Featured drugs

How to use this

• Patients: compare your country's price to international peers; check copay assistance programs from the manufacturer for US patients
• Payers / employers: benchmark formulary placement against international reimbursement decisions
• BD / corp dev: price-aware competitive intel for asset valuation
• Researchers: cost-effectiveness studies using consistent international list-price reference

Coverage notes

• ~40% of marketed drugs in our index have tracked pricing data — we expand quarterly
• Coverage is densest for US, UK, Germany, France, Italy, Spain, Canada, Australia, Japan
• List prices in local currency are authoritative; annual_cost_usd is FX-converted

Related

• Cost-per-QALY calculator — value-based price modelling
• US drug landscape · UK · Germany
• Biosimilar tracker — post-cliff price erosion